Latest filing published 29 May 2026 for Kyverna Therapeutics, Inc..
No signal scores available.
This profile gathers the share dealings of Mert Aktar in Kyverna Therapeutics, Inc. In total, 2 filings cover trades dated from 29 May 2025 to 27 May 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 May 2026 came the latest disclosure, a share grant in Kyverna Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations